Gheuens Sarah bought VRDN
July 1, 2025 · Form 4 insider transaction
Gheuens Sarah bought 21,000 shares of Viridian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
21,000
Price
$0.00
Total value
N/A
InsiderGheuens Sarah
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2025
Filing dateJuly 2, 2025
Shares owned after21,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.